The price of Tirelizumab (100mg/branch) is more than one thousand dollars, the specific price may be different by the impact of local health insurance policy, the specific price is recommended to consult the local health insurance agencies or hospitals.
Tirilizumab is a domestically produced PD-1 immunosuppressant, which is suitable for locally advanced or metastatic squamous non-small cell lung cancer, Hodgkin’s lymphoma after the failure of second-line treatment. The current price of a single unit is around 1,000 yuan, and the specific price may vary depending on the medical insurance policy of each place.
Tirelizumab may have side effects such as rash, fever, cough, decreased white blood cells, abnormal liver function, weight gain, autoimmune pneumonia, autoimmune nephritis, autoimmune hepatitis, etc. It is forbidden for those who are allergic to it, and the process of using it should be careful to monitor the occurrence of autoimmune diseases.
The drug should be applied under the guidance of a doctor and not applied on its own.